top of page

We Improve Patient
Quality Of Life

EndoProtech Inc. develops novel liposome-based therapies to treat microvascular dysfunction and myocardial infarction.

cardiac catheterization procedure_blue.jpg

Our Research

See our unique perspective on anti-inflammatory Liposomes that modify the composition of cell plasma membranes to reduce microvascular dysfunction.

Our research changes the course of how we see and experience therapeutic solutions. 

• Reduces Side Effects

• Reduces Recovery Time

• Preserves Tissue Viability

Team Chemistry

Claudio Maldonado, PhD

Founder, President

and CEO

gustavo perez-abadia_fade_bw.jpg

Gustavo Perez-Abadia, MD

Founder, Vice President

and Treasurer


Federico Grossi, MD/PhD



phillip bauer_fade_bw.jpg

Philip Bauer, PhD

Board Secretary

and Senior Scientist


Experience The Possibilities

The More Original A Discovery, The More Obvious It Seems Afterwards”

– Authur Koestler


Looking at microvascular dysfunction following ischemia/reperfusion injury

A Novel Approach to Reduce Infarct Size Following Myocardial Infarction

bottom of page